Chlamydia: The Silent Threat That Goes Undiagnosed

Chlamydia is the most common bacterial STD in the United States — and the most commonly missed. The CDC estimates that more than 1.6 million cases are reported each year, but the real number is thought to be significantly higher because the majority of people who have it never develop symptoms. It spreads silently, causes lasting damage if untreated, and is curable with a single course of antibiotics if caught in time. The problem is that "in time" rarely happens without deliberate testing, because most people with chlamydia have no reason to suspect they have it.

In my clinical experience, chlamydia is most dangerous not because it's hard to treat but because it goes undetected for months or years. By the time complications appear — pelvic inflammatory disease, infertility, epididymitis — the window for simple treatment has long passed.

Why Chlamydia Is So Often Undiagnosed

Up to 75% of women and approximately 50% of men with chlamydia have no symptoms at all. This is not a feature unique to mild cases — it applies across the full spectrum of infections. There is no reliable way to know you have chlamydia without testing. Symptoms, when they do occur, are easy to dismiss: a slight increase in vaginal discharge, mild burning on urination, or a vague pelvic discomfort that seems like something else. Many people attribute these to a yeast infection, a UTI, or stress and never seek care.

The window period — the time between infection and when a test can reliably detect it — is typically 1 to 2 weeks for urine-based NAAT testing. Testing too early after exposure can return a false negative. This means that even people who do get tested may miss an infection if they test immediately after a risky encounter.

Who Is Most at Risk

The CDC recommends annual chlamydia screening for all sexually active women under 25, and for older women with new or multiple partners. Men who have sex with men should be screened at all sites of exposure — urethra, rectum, and throat — at least annually, more often with multiple partners. Heterosexual men are not routinely screened in most clinical settings, which is one reason male chlamydia frequently goes undetected and untreated.

Risk factors include: age under 25 (the highest-prevalence group), new or multiple sexual partners, inconsistent condom use, previous STD diagnosis, and a partner with a known STD. Having one risk factor doesn't guarantee infection — but it does mean routine testing is justified regardless of symptoms.

What Chlamydia Does to the Body When Untreated

Untreated chlamydia can ascend from the cervix or urethra into the reproductive tract over weeks to months. In women, this causes pelvic inflammatory disease (PID) — infection of the uterus, fallopian tubes, and ovaries. PID is a leading cause of preventable infertility and ectopic pregnancy in the US. The CDC estimates that 10–15% of women with untreated chlamydia will develop PID. Repeated infections significantly increase this risk.

In men, untreated chlamydia can cause epididymitis — inflammation of the tube that carries sperm from the testicle. This can cause pain, swelling, and in severe or recurrent cases, reduced fertility. Reactive arthritis — joint inflammation triggered by the immune response to chlamydia — is another possible complication affecting both sexes, typically manifesting as knee, ankle, or foot swelling appearing 1–4 weeks after infection.

Chlamydia during pregnancy increases the risk of preterm birth, premature rupture of membranes, and neonatal infection. Infants born to mothers with untreated chlamydia can develop neonatal conjunctivitis and pneumonia.

How Chlamydia Is Tested

The standard test is a nucleic acid amplification test (NAAT) — the most sensitive method available. For women, this is typically a vaginal swab (self-collected or clinician-collected) or a urine sample. For men, a urine sample is standard. Throat and rectal swabs are used for people who engage in oral or anal sex.

Point-of-care rapid tests are available in some settings but are less sensitive than lab-based NAAT. If a rapid test is negative and clinical suspicion is high, confirmatory NAAT testing is appropriate. At-home test kits using self-collected samples sent to a certified lab are a reliable option for people who prefer not to visit a clinic.

Treatment

Chlamydia is curable with antibiotics. The standard treatment is doxycycline 100mg twice daily for 7 days, which the CDC now recommends over the previously standard single-dose azithromycin due to better efficacy data. Sexual partners from the previous 60 days (or the most recent partner if the last contact was over 60 days ago) should be tested and treated regardless of symptoms.

Abstain from sex for 7 days after completing treatment and until all recent partners have been treated. Retesting 3 months after treatment is recommended — not to check that treatment worked, but because reinfection from an untreated partner or a new exposure is common in the months following a positive test.

When to Seek Urgent Care

• Lower abdominal or pelvic pain in a sexually active woman: this may indicate PID developing from untreated chlamydia. PID requires prompt antibiotic treatment — see a clinician within 24 hours.

• Testicular pain or swelling: possible epididymitis — evaluate same day. Left untreated, epididymitis can cause permanent damage.

• Fever alongside genital symptoms: suggests the infection may have spread — requires urgent evaluation.

• Symptoms in pregnancy: any possible STD exposure or symptoms during pregnancy warrants immediate testing — untreated chlamydia has serious consequences for the fetus.

Frequently Asked Questions

Can you have chlamydia for years without knowing?

Yes. Because most infections cause no symptoms, chlamydia can persist undetected for months or years. During this time it can cause progressive damage to the reproductive tract. The only way to know is to test. This is why routine annual screening is recommended for all sexually active women under 25, regardless of symptoms or perceived risk.

Can chlamydia go away on its own?

In rare cases the immune system clears a chlamydia infection without treatment, but this is not reliably predictable and cannot be assumed. The risk of waiting is that untreated infection continues to damage the reproductive tract and remains transmissible to partners. Treatment with antibiotics is the only way to reliably clear the infection.

How soon after exposure can chlamydia be detected?

NAAT testing can typically detect chlamydia 1–2 weeks after exposure. Testing earlier than this risks a false negative result. If you test negative shortly after a high-risk encounter, retesting at 2–3 weeks is advisable if concern remains.

Can you get chlamydia from oral sex?

Yes, though it's less common. Chlamydia can infect the throat (pharynx) through oral sex. Pharyngeal chlamydia is typically asymptomatic and won't be detected by a standard urine test — a throat swab is needed. People who engage in oral sex regularly should discuss site-specific testing with their provider.

Does a negative chlamydia test mean my partner doesn't have it?

No. A negative test means you tested negative at the time of testing. It doesn't indicate your partner's status. Partners should be tested independently. If your partner tests positive, you should be tested and treated regardless of your own test result, since there may have been exposure prior to a detectable window.

Get Tested

Chlamydia testing takes a few minutes and requires nothing more than a urine sample or a swab. Results are typically available within 1–2 days through private testing. If you're sexually active and haven't been tested recently, this is the most important step you can take for your long-term reproductive health.

Confidential, same-day testing is available near you. In Texas: Houston and Dallas. In Florida: Jacksonville and Tampa. On the West Coast: Los Angeles. In the mid-Atlantic: Washington DC.

Related reading: Chlamydia Treatment: Everything You Need to Know · STDs and Joint Pain · STDs and Pregnancy · Asymptomatic STDs